Evodiamine suppresses non-small cell lung cancer by elevating CD8(+) T cells and downregulating the MUC1-C/PD-L1 axis

BACKGROUND: Accumulating evidence showed that regulating tumor microenvironment plays a vital role in improving antitumor efficiency. Programmed Death Ligand 1 (PD-L1) is expressed in many cancer cell types, while its binding partner Programmed Death 1 (PD1) is expressed in activated T cells and ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Ze-Bo, Huang, Ju-Min, Xie, Ya-Jia, Zhang, Yi- Zhong, Chang, Chan, Lai, Huan-Ling, Wang, Wenjun, Yao, Xiao-Jun, Fan, Xing-Xing, Wu, Qi-Biao, Xie, Chun, Wang, Mei-Fang, Leung, Elaine Lai-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677782/
https://www.ncbi.nlm.nih.gov/pubmed/33208183
http://dx.doi.org/10.1186/s13046-020-01741-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677782/
https://www.ncbi.nlm.nih.gov/pubmed/33208183
http://dx.doi.org/10.1186/s13046-020-01741-5

Ejemplares similares